IBDEI113 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17111,0)
 ;;=G58.9^^88^857^100
 ;;^UTILITY(U,$J,358.3,17111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17111,1,3,0)
 ;;=3^Neuropathy,Mononeuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,17111,1,4,0)
 ;;=4^G58.9
 ;;^UTILITY(U,$J,358.3,17111,2)
 ;;=^5004065
 ;;^UTILITY(U,$J,358.3,17112,0)
 ;;=G54.9^^88^857^102
 ;;^UTILITY(U,$J,358.3,17112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17112,1,3,0)
 ;;=3^Neuropathy,Nerve Root/Plexus Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,17112,1,4,0)
 ;;=4^G54.9
 ;;^UTILITY(U,$J,358.3,17112,2)
 ;;=^5004015
 ;;^UTILITY(U,$J,358.3,17113,0)
 ;;=G54.6^^88^857^103
 ;;^UTILITY(U,$J,358.3,17113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17113,1,3,0)
 ;;=3^Neuropathy,Phantom Limb Syndrome w/ Pain
 ;;^UTILITY(U,$J,358.3,17113,1,4,0)
 ;;=4^G54.6
 ;;^UTILITY(U,$J,358.3,17113,2)
 ;;=^5004013
 ;;^UTILITY(U,$J,358.3,17114,0)
 ;;=G54.7^^88^857^104
 ;;^UTILITY(U,$J,358.3,17114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17114,1,3,0)
 ;;=3^Neuropathy,Phantom Limb Syndrome w/o Pain
 ;;^UTILITY(U,$J,358.3,17114,1,4,0)
 ;;=4^G54.7
 ;;^UTILITY(U,$J,358.3,17114,2)
 ;;=^5004014
 ;;^UTILITY(U,$J,358.3,17115,0)
 ;;=G62.2^^88^857^105
 ;;^UTILITY(U,$J,358.3,17115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17115,1,3,0)
 ;;=3^Neuropathy,Polyneuropathy d/t Toxic Agents
 ;;^UTILITY(U,$J,358.3,17115,1,4,0)
 ;;=4^G62.2
 ;;^UTILITY(U,$J,358.3,17115,2)
 ;;=^268531
 ;;^UTILITY(U,$J,358.3,17116,0)
 ;;=G62.82^^88^857^94
 ;;^UTILITY(U,$J,358.3,17116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17116,1,3,0)
 ;;=3^Neuropathy,Drug-Induced Polyneuropathy
 ;;^UTILITY(U,$J,358.3,17116,1,4,0)
 ;;=4^G62.82
 ;;^UTILITY(U,$J,358.3,17116,2)
 ;;=^5004077
 ;;^UTILITY(U,$J,358.3,17117,0)
 ;;=G62.9^^88^857^106
 ;;^UTILITY(U,$J,358.3,17117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17117,1,3,0)
 ;;=3^Neuropathy,Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,17117,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,17117,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,17118,0)
 ;;=G57.90^^88^857^99
 ;;^UTILITY(U,$J,358.3,17118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17118,1,3,0)
 ;;=3^Neuropathy,Mononeuropathy,Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,17118,1,4,0)
 ;;=4^G57.90
 ;;^UTILITY(U,$J,358.3,17118,2)
 ;;=^5004061
 ;;^UTILITY(U,$J,358.3,17119,0)
 ;;=G56.90^^88^857^101
 ;;^UTILITY(U,$J,358.3,17119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17119,1,3,0)
 ;;=3^Neuropathy,Mononeuropathy,Upper Limb,Unspec
 ;;^UTILITY(U,$J,358.3,17119,1,4,0)
 ;;=4^G56.90
 ;;^UTILITY(U,$J,358.3,17119,2)
 ;;=^5004035
 ;;^UTILITY(U,$J,358.3,17120,0)
 ;;=R29.5^^88^857^107
 ;;^UTILITY(U,$J,358.3,17120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17120,1,3,0)
 ;;=3^Paralysis,Transient
 ;;^UTILITY(U,$J,358.3,17120,1,4,0)
 ;;=4^R29.5
 ;;^UTILITY(U,$J,358.3,17120,2)
 ;;=^5019316
 ;;^UTILITY(U,$J,358.3,17121,0)
 ;;=G83.9^^88^857^108
 ;;^UTILITY(U,$J,358.3,17121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17121,1,3,0)
 ;;=3^Paralytic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,17121,1,4,0)
 ;;=4^G83.9
 ;;^UTILITY(U,$J,358.3,17121,2)
 ;;=^5004151
 ;;^UTILITY(U,$J,358.3,17122,0)
 ;;=G82.20^^88^857^109
 ;;^UTILITY(U,$J,358.3,17122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17122,1,3,0)
 ;;=3^Paraplegia,Unspec
 ;;^UTILITY(U,$J,358.3,17122,1,4,0)
 ;;=4^G82.20
 ;;^UTILITY(U,$J,358.3,17122,2)
 ;;=^5004125
 ;;^UTILITY(U,$J,358.3,17123,0)
 ;;=G21.9^^88^857^111
 ;;^UTILITY(U,$J,358.3,17123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17123,1,3,0)
 ;;=3^Parkinsonism,Secondary,Unspec
 ;;^UTILITY(U,$J,358.3,17123,1,4,0)
 ;;=4^G21.9
 ;;^UTILITY(U,$J,358.3,17123,2)
 ;;=^5003778
